NCT00035698

Brief Summary

To identify genes involved in obesity.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,027

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2001

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2001

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2002

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 6, 2002

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2009

Completed
Last Updated

March 17, 2017

Status Verified

March 1, 2017

Enrollment Period

7.1 years

First QC Date

May 4, 2002

Last Update Submit

March 16, 2017

Conditions

Cardiovascular DiseasesObesityHeart Diseases

Outcome Measures

Primary Outcomes (1)

  • This was an observational study, consequently there were no outcomes.

    This was an observational study, consequently there were no outcomes.

    1997-2009

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

In this study the amount of the gene product in the different tissue samples for the candidate genes will be analyzed. The study design is to compare the expression of genes in cell lines with different genetic variants for genes hypothesized to influence obesity or body mass index and located on chromosome 7. Genetic variants which distinguish the expression of genes will be investigated in other samples derived from this or similar studies. No drug intervention. No patient contacts for this research. No subject participation for this research, which is carried out on existing cell lines, data and DNA. The study will continue until the gene is found or we fail to obtain funding renewal. The expected duration of this component of our study is approximately 4 years.

The PI was not involved in the study recruitment or examination of the subjects form which the adipose samples were obtained and all data were de-identified.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Biospecimen

Retention: NONE RETAINED

This study ended years ago, I do not know why I am being asked to update it as a clinical trial. It was never a clinical trial.

MeSH Terms

Conditions

Cardiovascular DiseasesObesityHeart Diseases

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Richard Myers, PhD

    Boston University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2002

First Posted

May 6, 2002

Study Start

December 1, 2001

Primary Completion

January 1, 2009

Study Completion

January 1, 2009

Last Updated

March 17, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share